This paper investigated the effects of delayed centrifugation, delayed analysis, and frozen storage on the measured levels of B-type natriuretic peptide (BNP) in plasma from healthy patients and those with heart conditions.
In vitro stability of B-type natriuretic peptide (BNP) in plasma stored under different conditions when measured with the Lumipulse<sup>®</sup> assay.
García de Guadiana-Romualdo L, Ramos-Arenas V, Campos-Rodríguez V, Consuegra-Sánchez L, Albaladejo-Otón MD
Purpose
Conclusion
BNP levels decreased significantly with post-centrifugation storage at either temperature with changes exceeding the acceptable limit occurring at both temperatures after more than 12 h in specimens from healthy patients and more than 4 h in specimens from acute coronary syndrome patients. BNP concentrations were not affected when blood was stored at room temperature for 4 h before centrifugation or when plasma was stored frozen for up to 3 months, regardless of diagnosis.
Studies (2)
Purpose
This study investigated the effects of delayed centrifugation and delayed analysis on the measured levels of BNP in plasma from healthy patients and those with acute coronary disease. Blood was collected from six healthy patients and five intensive care unit patients with acute coronary syndrome into two EDTA Vacutainer tubes. One tube was immediately centrifuged and BNP levels in plasma were than assayed after 0, 4, 12, 24, 48, and 72 h of storage at room temperature or 4°C. The other tube was stored for 4 h before centrifugation at 3500 rpm for 10 min and then BNP levels were assayed immediately. BNP was assayed using a chemiluminescence immunoassay on a LUMIPULSE 600II G analyzer.
Summary of Findings
BNP levels decreased significantly with post-centrifugation storage at either temperature. During room temperature storage, the percent deviation exceeded the acceptable limit (4.8% for healthy patients and 4.1% for acute coronary syndrome patients) when specimens from healthy patients were stored for more than 12 h or specimens from acute coronary syndrome patients were stored for more than 4 h. During refrigerated storage, the percent deviation exceeded the acceptable limit when specimens from healthy patients were stored for more than 12 h or specimens from acute coronary syndrome patients were stored for more than 4 h. BNP concentrations were stable when blood from either group was stored at room temperature for 4 h before centrifugation.
Biospecimens
FluidBloodFluidPlasmaPreservation Types
None (Fresh)Diagnoses
Coronary Artery DiseaseNormalPlatforms
PeptideClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Acute coronary syndromeHealthyBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedStorage Storage duration 0 h12 h24 h4 h48 h72 hStorage Storage temperature 4°CRoom temperatureStorage Time at room temperature 0 h4 h
Purpose
This study investigated the effects of frozen storage on the measured levels of BNP in plasma from healthy patients and those with decompensated heart failure. Blood was collected into EDTA Vacutainer tubes from five healthy patients and five intensive care unit patients with acute decompensated heart failure. Blood was immediately centrifuged at 3500 rpm for 10 min. Plasma was stored frozen at -20°C and assayed after 1 and 3 months. BNP was assayed using a chemiluminescence immunoassay on a LUMIPULSE 600II G analyzer.
Summary of Findings
BNP concentrations in plasma were not affected by up to 3 months of frozen storage, regardless of diagnosis.
Biospecimens
FluidPlasmaPreservation Types
FrozenDiagnoses
NormalCardiovascular DiseasePlatforms
PeptideClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Decompensated heart failureHealthyStorage Storage duration 1 month3 months